Lamotrigine

What lamotrigine is used for

The FDA-approved psychiatric indication is maintenance treatment of bipolar I disorder to delay the recurrence of mood episodes. It's used off-label for:

• bipolar depression (some evidence, weaker than for maintenance)
• bipolar II disorder maintenance
• augmentation of antidepressants in treatment-resistant unipolar depression (some evidence, weaker than for bipolar)
• borderline personality disorder (some evidence for reducing mood instability)
• depersonalization-derealization disorder (small trials)

It's also used for epilepsy, its original indication.

How it works

The mechanism isn't fully worked out. Lamotrigine blocks voltage-sensitive sodium channels and modulates glutamate release. The clinical effect (mood stabilization, particularly against depression) doesn't map cleanly onto any single receptor mechanism, which is common for older mood stabilizers. PsychiatryRx's interactive synapse guide shows what lamotrigine does in the brain alongside the other mood stabilizers.

Clinically, the pattern is: better evidence for preventing depressive episodes than manic episodes in bipolar disorder, more useful in the depressive pole of bipolar illness, and modest effect against active mania.

The slow titration

Lamotrigine has to be started at a low dose (typically 25 mg per day) and increased slowly, usually doubling every two weeks, to reach a target dose of 200 mg per day for bipolar maintenance. Faster titration substantially increases the risk of a serious skin reaction (see below). This means the medication takes weeks to reach full dose.

For patients also on valproate (which raises lamotrigine levels), the titration is even slower and the target dose lower (usually 100 mg per day). For patients on medications that lower lamotrigine levels (carbamazepine, phenytoin, some other agents), a higher target dose may be needed.

The slow onset is a real limitation. For acute mood episodes, faster-acting treatments are usually chosen first.

The rash question

The main safety concern with lamotrigine is a skin reaction. Most rashes on lamotrigine are ordinary and resolve when the medication is stopped. A small subset are serious: Stevens-Johnson syndrome or toxic epidermal necrolysis, which are life-threatening.

Rates of the serious reaction are around 0.1 percent in adults with slow titration, higher with faster titration, higher in children, and higher when lamotrigine is combined with valproate without dose adjustment.

Any new rash on lamotrigine deserves prompt attention. Rashes with fever, mouth or eye involvement, or that are spreading rapidly are emergencies.

For patients who have had a lamotrigine rash previously, rechallenge is not usually recommended.

What to expect starting it

The first weeks are titration. The therapeutic effect for mood stabilization typically emerges over weeks to months, not days. For maintenance in bipolar disorder, the effect is measured by absence of mood episodes over time, not by acute change.

Common side effects that are usually mild:

• headache
• nausea
• dizziness
• fatigue in the first weeks
• occasional blurred vision

Less common but worth noting:

• rash (as above)
• rare hematologic effects
• rare hepatic effects
• rare hypersensitivity syndromes

Cognitive effects and weight gain are less common than with several other mood stabilizers, which is one reason lamotrigine is often chosen for people particularly bothered by those on other agents.

What lamotrigine is not

Lamotrigine is not a first-line acute treatment for mania. Its onset is too slow, and the evidence for anti-manic effect is weaker than for lithium or antipsychotics.

Lamotrigine is not a strong antidepressant on its own for unipolar depression. It's used in that context as augmentation for depression that hasn't responded to other approaches, with modest evidence.

Lamotrigine is not a treatment for anxiety disorders. It's sometimes used off-label but doesn't have strong evidence.

Interactions

Several important interactions to know:

• Valproate substantially raises lamotrigine levels. When the two are combined, lamotrigine is titrated more slowly and to lower target doses.
• Estrogen-containing hormonal contraceptives lower lamotrigine levels. Doses may need adjustment when starting or stopping the contraceptive.
• Carbamazepine, phenytoin, and some other agents lower lamotrigine levels.

Any medication changes on lamotrigine deserve a conversation with the prescriber before making them.

Pregnancy and breastfeeding

Lamotrigine has one of the better safety profiles among anticonvulsant mood stabilizers in pregnancy. It's often the first choice among mood stabilizers when pregnancy is a possibility, though decisions are individualized.